Wikipedia -WSS

Wikipedia

author：explore 2025-10-02 22:24:11 - browse：81568

FDA stop sign — Sarah Silbiger/Getty Images

The Food and Drug Administration is cracking down on websites that claim to sell the underlying chemicals of popular diabetes and obesity drugs like Ozempic, Wegovy, and Zepbound, saying that the websites are selling unapproved and misbranded drug products.

The regulator this week posted warning letters that it sent to two websites, Synthetix Inc. DBA Helix Chemical Supply and US Chem Labs. Though those websites say their chemicals are “for research use” and “not for human consumption,” the FDA said it found evidence on their pages showing that their products are indeed intended for human use, such as information about dosing and claims about the clinical benefits of the products.

The two websites did not immediately respond to requests for comment. The FDA said they have 15 working days to respond and detail the steps they’ve taken to address any violations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Sanders adds drug shortage policies to pandemic preparedness bill

WSS

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

New oral drug delivery patch is modeled after octopus tentacles

focus

Wikipedia

hotspot

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Lawsuit highlights wrinkle for disputes over surprise medical bills

Wildfire smoke exposes gaps in outdoor worker protections

Doctors find melanoma drugs effective against rare brain cancer

Anesthesiologist group: stop taking Ozempic before surgery

Experts study whether long Covid risk adds up with each reinfection

Dobbs anniversary: the lost opportunity of abortion as health care

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

Supreme Court strikes down use of affirmative action

New oral drug delivery patch is modeled after octopus tentacles

hotspot

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

Stop Congress from blocking public access to science

Custom gene therapy hints at new path for rare disease treatments

Flu, Covid vaccination rates decline, new survey data show

CDC picks Alphabet's Verily for wasterwater surveillance contract

The United States is paying nearly triple for new Covid vaccines

knowledge

focus

leisure time

explore